Ebola experimental vaccines are being administered to some while others are left to fight the disease alone after the latest outbreak, which has now killed over 1,000 people. The U.S. Department of Defense has now given approval and funding to a biopharmaceutical company in Iowa to test a new Ebola vaccine on humans. Is there enough of a market for these drugs? We look at how the availability of these drugs could increase, in this Lip News clip with Gabriel Mizrahi and Lissette Padilla.
Newest Lip News playlist:
http://ift.tt/1uTmHnz
BUZZSAW interview clips –
http://ift.tt/1kzfMze
CRIME TIME clips playlist –
http://ift.tt/VgP6aR
BYOD (Bring Your Own Doc) Highlight Videos-
http://ift.tt/1ul3JJa
MEDIA MAYHEM short videos playlist –
http://ift.tt/1l0G5Pw